Cellular and developmental control of O2 homeostasis by hypoxia- inducible factor 1α

Genes and Development

Volumn 12, Issue 2, 1998, Pages 149-162

  Iyer, Narayan V ^a   Kotch, Lori E ^a   Agani, Faton ^a   Leung, Sandra W ^a   Laughner, Erik ^a   Wenger, Roland H ^b   Gassmann, Max ^b   Gearhart, John D ^a   Lawler, Ann M ^a   Yu, Aimee Y ^a   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cardiovascular development; Glycolysis; Knockout; Oxygen; VEGF

Indexed keywords

6 PHOSPHOFRUCTOKINASE; AROMATIC HYDROCARBON RECEPTOR; ENOLASE; ERYTHROPOIETIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUCOSE TRANSPORTER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MESSENGER RNA; OXYGEN; PHOSPHOGLUCOMUTASE; PHOSPHOGLYCERATE KINASE; PYRUVATE KINASE; TRANSCRIPTION FACTOR; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MALFORMATION; CELL DEATH; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIMERIZATION; EMBRYO; EMBRYO CELL; FEMALE; GLYCOLYSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOXIA; MALE; MESENCHYME; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 15444342958     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.2.149     Document Type: Article

References (60)

1. Andersen, B. and M.G. Rosenfeld. 1994. Pit-1 determines cell types during development of the anterior pituitary gland: A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J. Biol. Chem. 269:29335-29338.
2. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl, L.M. Albright, D. Coen, M.A. Varki, and K. Janssen. 1994. Current protocols in molecular biology. John Wiley and Sons, New York, NY.
3. Benjamin, L.E. and E. Keshet. 1997. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci 94: 8761-8766.
4. Bradley, A. 1987. Production and analysis of chimaeric mice. In Teratocarcinomas and embryonic stem cells: A practical approach, 1st ed. (ed. E.J. Robertson), pp. 113-152. IRL Press, Oxford, UK.
5. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertesenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
6. Carroll, R.C., J.F. Ash, P.K. Vogt, and S.J. Singer. 1978. Reversion of transformed glycolysis to normal by inhibition of protein synthesis in rat kidney cells infected with temperature-sensitive mutant of Rous sarcoma virus. Proc. Natl. Acad. Sci. 75:5015-5019.
7. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
8. Dolwick, K.M., H.I. Swanson, and C.A. Bradfield. 1993. In vitro analysis of Ah receptor domains involved in ligand-activated transcription. Proc. Natl. Acad. Sci. 90: 8566-8570.
9. Ema, M., S. Taya, N. Yokotani, K. Sogawa, Y. Matsuda, and Y. Fujii-Kuriyama. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. 94: 4273-4278.
10. Ferrara, N. and T. Davis-Smyth. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18: 4-25.
11. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea, L. Powell-Braxton, K.J. Hillan, and M.W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
12. Flamme, I., T. Frohlich, M. von Reutern, A. Kappel, A. Damert, and W. Risau. 1997. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels. Mech. Dev. 63: 51-60.
13. Forsythe, J.A., B.-H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, and G.L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell. Biol. 16: 4604-613.
14. Gassmann, M., J. Fandrey, S. Eichet, M. Wartenberg, H.H. Marti, C. Bauer, R.H. Wenger, and H. Acker. 1996. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc. Natl. Acad. Sci. 93: 2867-2872.
15. Guillemin, K. and M.A. Krasnow. 1997. The hypoxic response: Huffing and HIFing. Cell 89: 9-12.
16. Henkemeyer, M., D.J. Rossi, O.P. Holmyard, M.C. Puri, G. Mbamalu, K. Harpal, T.S. Shih, T. Jacks, and T. Pawson. 1995. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature 377: 695-701.
17. Hirose, K., M. Morita, M. Ema, J. Mimura, H. Hamada, H. Fujii, Y. Saijo, O. Gotoh, K. Sogawa, and Y. Fujii-Kuriyama. 1996. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol. Cell. Biol. 16: 1706-1713.
18. Hoffman, E.C., H. Reyes, F.-F. Chu, F. Snader, L.H. Conley, B.A. Brooks, and O. Hankinson. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252: 954-958.
19. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Hogenesch, J.B., W.K. Chan, V.H. Jackiw, R.C. Brown, Y.-Z. Gu, G.H. Perdew, and C.A. Bradfield. 1997. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signalling pathway. J. Biol. Chem. 272: 8581-8593.
21. Ikeda, E., M.G. Achen, G. Breier, and W. Risau. 1995. Hypoxiainduced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:19761-19766.
22. Jiang, B.-H., E. Rue, G.L. Wang, R. Roe, and G.L. Semenza. 1996a. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol Chem. 271: 17771-17778.
23. 2 tension. Am. J. Physiol. 271:C1172-C1180.
24. Jiang, B.-H., F. Agani, A. Passaniti, and G.L. Semenza. 1997a. V-SRC induces expression of hypoxia-inducible factor 1 and transcription of genes encoding VEGF and enolase 1: Involvement of HIF-I in tumor progression. Cancer Res. 57: 5328-5335.
25. Jiang, B.-H., J.Z. Zheng, S.W. Leung, R. Roe, and G.L. Semenza. 1997b. Transactivation and inhibitory domains of hypoxia-inducible factor 1α Modulation of transcriptional activity by oxygen tension. J. Biol Chem. 272: 19253-19260.
26. Kotch, L.E., S.-Y. Chen, and K.K. Sulik. 1995. Ethanol-induced teratogenesis: Free radical damage as a possible mechanism. Teratology 52: 128-136.
27. Lennon, G., C. Auffray, M. Polymeropoulos, and M.B. Soares. 1996. The I.M.A.G.E. consortium: An integrated molecular analysis of genomes and their expression. Genomics 33: 151-152.
28. Levy, A.P., N.S. Levy, S. Wegner, and M.A. Goldberg. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340.
29. Levy, A.P., N.S. Levy, and M.A. Goldberg. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271: 2746-2753.
30. Li, E., T.H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
31. Lindahl, P., B.R. Johansson, P. Leveen, and C. Betsholtz. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277: 242-245.
32. Liu, Y., S.R. Cox, T. Morita, and S. Kourembanas. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ. Res. 77: 638-643.
33. Maltepe, E., J.V. Schmidt, D. Baunoch, C.A. Bradfield, and C. Simon. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386: 403-407.
34. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int- 2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336: 348-352.
35. Martin, C., A.Y. Yu, B.-H. Jiang, L. Davis, D. Kimberly, A.R. Hohimer, and G.L. Semenza. 1997. Cardiac hypertrophy in chronically anemic sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. (in press).
36. Moffett, P., M. Reece, and J. Pelletier. 1997. The murine Sim-2 gene product inhibits transcription by active repression and functional interference. Mol. Cell. Biol. 17: 4933-4947.
37. Mortensen, R.M., D.A. Conner, S. Chao, A.A.T. Geisterfer-Lowrance, and J.G. Seidman. 1992. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12:2391-2395.
38. Orkin, S.H. 1992. GATA-binding transcription factors in hematopoietic cells. Blood 80: 575-581.
39. Pugh, C.W., J.F. O'Rourke, M. Nagao, J.M. Gleadle, and P.J. Ratcliffe. 1997. Activation of hypoxia-inducible factor 1: Definition of regulatory domains within the α subunit. J. Biol. Chem. 272: 11205-11214.
40. Ramirez-Solis, R., J. Rivera-Perez, J.D. Wallace, M. Wims, H. Zheng, and A. Bradley. 1992. Genomic DNA microextraction: A method to screen numerous samples. Anal. Biochem. 201:331-335.
41. Robertson, E.J. 1987. Embryo-derived stem cell lines. In Teratocarcinomas and embryonic stem cells: A practical approach, 1st ed. (ed. E.J. Robertson), pp. 71-112. IRL Press, Oxford, UK.
42. Salceda, S., I. Beck, and J. Caro. 1996. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch. Biochem. Biophys. 334: 389-394.
43. Schlaeger, T.M., Y. Qin, Y. Fujiwara, J. Magram, and T.N. Sato. 1995. Vascular endothelial cell lineage-specific promoter. Development 121: 1089-1098.
44. Semenza, G.L. and G.L. Wang. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12: 5447-5454.
45. Semenza, G.L., P.H. Roth, H.-M. Fang, and G.L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269: 23757-23763.
46. Semenza, G.L., B.-H. Jiang, S.W. Leung, R. Passantino, J.-P. Concordet, P. Maire, and A. Giallongo. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271: 32529-32537.
47. Shima, D.T., M. Kuroki, U. Deutsch, Y.-S. Ng, A.P. Adamis, and P.A. D'Amore. 1996. The mouse gene for vascular endothelial growth factor: Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271: 3877-3883.
48. Stein, I., M. Neeman, D. Shweiki, A. Itin, and E. Keshet. 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15: 5363-5368.
49. Tian, H., S.L. McKnight, and D.W. Russell. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes & Dev. 11: 72-82.
50. Wang, G.L. and G.L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270: 1230-1237.
51. 2 tension. Proc. Natl. Acad. Sci. 92:5510-5514.
52. Wang, L.C., F. Kuo, Y. Fujiwara, D.G. Gilliland, T.R. Golub, and S.H. Orkin. 1997. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16: 4374-4383.
53. Warburg, O. 1956. On respiratory impairment in cancer cells. Science 124:269-270.
54. Warren, A.J., W.H. Colledge, M.B.L. Carlton, M.J. Evans, A.J.H. Smith, and T.H. Rabbits. 1994. The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 78: 45-57.
55. Weintraub, H. 1993. The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75: 1241-1244.
56. Wenger, R.H. and M. Gassmann. 1997. Oxygen(es) and the hypoxia-inducible factor 1. Biol Chem. 378:609-616.
57. Wenger, R.H., A. Rolfs, H.H. Marti, J.-L. Guenet, and M. Gassmann. 1996. Nucleotide sequence, chromosomal assignment, and mRNA expression of mouse hypoxia-inducible factor 1α. Biochem. Biophys. Res. Commun. 223:54-59.
58. Wenger, R.H., A. Rolfs, I. Kvietikova, P. Spielmann, D.R. Zimmermann, and M. Gassmann. 1997. The mouse gene for hypoxia-inducible factor-la: Genomic organization, expression, and characterization of an alternative first exon and 5′ flanking sequence. Eur. J. Biochem. 246:155-165.
59. Wiener, C.M., G. Booth, and G.L. Semenza. 1996. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225: 485-488.
60. Wood, S.M., J.M. Gleadle, C.W. Pugh, O. Hankinson, and P.J. Ratcliffe. 1996. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression: Studies in ARNT-deficient cells. J. Biol. Chem. 271: 15117-15123.